4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-060041
President and CEO sold 3,490 shares at $5.17 ($18,043)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paulson Richard A. President and CEO | 2022-12-05 | Sale | −3,490 | $5.17 | $18,043 | 612,527 | D: show line 1 in the form |
| Open-market sales · 3,490 sh · avg $5.17 · $18,043 | |||||||
Loading xslF345X03/doc4.xml…